Daily Stock List
Game Plan Holdings, Inc. (GPLH)
Today we are reporting on Game Plan Holdings, Inc. (GPLH), here at the QualityStocks Daily Newsletter.
Listed on the OTCBB, Game Plan Holdings, Inc. owns and operates three internet web sites. These three are Hazzsports.com, Totalscout.com and CheckinSave.com. The Company's website servers and software development activities are conducted by third party vendors off-site. Game Plan Holdings' plan of operations in the coming months is to diversify their websites with many lines of corresponding products and services. Game Plan Holdings has their headquarters in Henderson, Nevada.
Their Hazzsports.com is an online social networking website. It offers an interactive resource for sports enthusiasts. The online community provides a site for athletes, sports fans, coaches as well as friends to network socially and professionally with each other.
The Company has their Totalscout.com offering. Totalscout.com provides college baseball coaches an easier and more efficient way to create and request scouting reports on opposing teams. Game Plan Holdings has developed an online-standardized reporting tool that has proven to reduce, significantly, the time and effort spent on scouting reports. The tool accessible at Totalscout.com has preloaded every college baseball player and every possible scouting attribute into an online database. This database then generates an online standard report, providing a readily recognizable and accessible scouting report.
Game Plan Holdings' most recent addition is CheckinSave.com. This is a social networking website where users check in at locations including restaurants, bars or theaters via the Company's website and accrue points for their check-ins. In addition, when "friends" the users are connected to on the website check-in to locations, the user accrues points. These points are subsequently redeemable for coupons and discounts at an array of registered venues.
The site is currently available to users in Vancouver, British Columbia and Las Vegas, Nevada. The Company's intention is to expand to a number of other metropolitan cities in North America. CheckinSave.com is part of the growth of Game Plan Holdings' business, in the Company's efforts to offer their members new and updated services.
Game Plan Holdings' revenues from March 25, 1999 (year of inception) to September 30, 2012 were minimal. The Company does not anticipate earning revenues until they enter into the final development stages of their websites whereby they can attract advertisers through their implementation of their business plan.
Game Plan Holdings, Inc. (GPLH), closed Friday's trading session at $0.20, up 25.00%, on 8,000 volume with 7 trades. The average volume for the last 60 days is 9,323 and the stock's 52-week low/high is $0.12/$0.371.
The Singing Machine Company, Inc. (SMDM)
We are reporting on The Singing Machine Company, Inc. (SMDM), here at the QualityStocks Daily Newsletter.
The Singing Machine Company, Inc. develops and distributes a complete line of consumer-oriented karaoke machines and music under The Singing Machine™, SMDigital™, SoundX™, and Sound X Kids™ and other brand names. The Company is the first to provide karaoke systems for home entertainment in the United States. Moreover, The Singing Machine Company is the first to offer digital music downloads for play on home karaoke machines. Incorporated in 1982, the Company lists on the OTC Bulletin Board and is based in Fort Lauderdale, Florida.
The Singing Machine Company established in California concentrating on professional and semi-professional karaoke equipment. They engage in the design, development, distribution, marketing and sale of consumer-oriented karaoke systems, youth electronics, musical instruments, accessories and Music under The Singing Machine®, Bratz™, SMDigital™ and Motown® brand names. The Company sells their products in North America, Australia, and Europe, and they have operations in Florida, California, Macau and Hong Kong.
Furthermore, they produce and market karaoke music, including CD plus graphics (CD+G's), containing music and lyrics of popular songs for use with karaoke recording equipment. They contract for the reproduction of music recordings with independent studios.
In 2009, The Singing Machine Company launched the online karaoke music download business through a partnership with content provider, Stingray Digital. The Singing Machine Company became the first karaoke company to provide legal karaoke downloads with an extensive selection of more than 8,000 karaoke titles.
Yesterday, The Singing Machine Company announced the results for their third fiscal quarter ended December 31, 2012. They reported third-quarter net sales of approximately $16.6 million, compared to net sales of approximately $8.7 million in the same quarter last year. This represents an increase of 90 percent. They also posted quarterly net income of approximately $1.4 million for the quarter ($0.04 per share), and year-to-date net income of approximately $2.4 million ($0.06 per share). Gross margin was 24.2 percent in comparison to 20.8 percent in the year-prior quarter.
The Singing Machine Company, Inc. (SMDM), closed Friday's trading session at $0.20, up 5.88%, on 161,639 volume with 28 trades. The average volume for the last 60 days is 5,703 and the stock's 52-week low/high is $0.06/$0.3949.
Colorado Gold Mines, Inc. (CGLD)
Otcstockexchange, Whisper from Wall Street, Stockgoodies, Penny Stock Newsletter, Damn Good Penny Picks, PREPUMPSTOCKS, Club Penny Stocks Network, Stock Legends, WiseAlerts, StockBomb.com, StockLockandLoad, StockRockandRoll, and PennyStockLocks.com reported recently on Colorado Gold Mines, Inc. (CGLD), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Colorado Gold Mines, Inc. is a development stage company engaged in the acquisition, exploration, development, and mining and processing of precious metal properties. The Company's operating interest includes the development stage Keeno Strike Silver and Gold Property located in the southern end of the Spring Mountains in the Yellow Pine Mining District of Southern Nevada. The mining claims are current with the United States Bureau of Land Management (BLM) and Clark County, Nevada. Colorado Gold Mines lists on the OTC Bulletin Board. The Company is based in Las Vegas, Nevada.
The Keeno Strike Silver Property is favorably located in close proximity to existing infrastructure. This includes Jean, Nevada just off Interstate 15, a regional airport, rail, water supplies, telephone services, gas and electrical power. In addition, there are several existing historical mine workings in the region. A variety of deposits and showings containing silver, gold and lead occur within a mile of the claims in the same type of deposit exposed on the property.
In January, Colorado Gold Mines announced that they signed an agreement granting the Company an option to purchase the Keeno Strike Gold and Silver Property. The Keeno property consists of 12 unpatented 20-acre lode-mining claims and one 5-acre mill site claim located in Clark County, Nevada. The claims are near the historical Monte Cristo Mine and the Keeno-Mint workings near Porter Wash in Clark County.
The Keeno Strike Property is approximately 30 miles southwest of Las Vegas in the historical mining district known as the Goodsprings District. This District contains deposits of gold, silver, copper, cobalt nickel, zinc and lead. By the end of 1962, the Goodsprings district had yielded 109,000 tons of zinc, 147,000 tons of lead, 2,500 tons of copper, 900,500 ounces of gold, and 120,100,000 ounces of silver, 5 tons of cobalt and 1,200 ounces of platinum group metals (PGMs).
Colorado Gold Mines, Inc. (CGLD), closed Friday's trading session at $0.25, down 10.71%, on 4,750 volume with 3 trades. The average volume for the last 60 days is 20,229 and the stock's 52-week low/high is $0.22/$1.10.
Elephant Talk Communications Corp. (ETAK)
The Street reported recently on Elephant Talk Communications Corp. (ETAK), Wall Street Corner, Investor Ideas, SmallCap Network did earlier, and we are highlighting the Company today, here at the QualityStocks Daily Newsletter.
Elephant Talk Communications Corp. is a foremost worldwide provider of proprietary Software Defined Network (SDN) platforms for the telecommunications industry. These platforms empower Mobile Network Operators and Mobile Virtual Network Operators, Enablers and Aggregators with a complete portfolio of Applications. Elephant Talk's customers include many of the world's leading Mobile Operators. These include Vodafone, T-Mobile and Zain, and virtually all business focuses on tier 1 and tier 2 operators around the world.
The Company's suite includes Full OSS/BSS Systems, Delivery Platforms, Support and Managed Services, on-site, cloud, hybrid and S/PaaS solutions, including Network, Mobile Internet ID Solutions, Secure Remote Access Management, Loyalty Management and Transaction Processing Services. Their suite also includes premier Industry Expertise and Customer Service without major upfront investment.
Integration of Elephant Talk's own applications with the telecommunication services provided by their Mobile Virtual Network Enabling (MVNE) platform is achieved using market standard interfaces – for example, Web Services.
ValidSoft Ltd. has been a wholly owned subsidiary of Elephant Talk since early 2010. ValidSoft supports Elephant Talk's mobile/cloud security offering. ValidSoft is a market leader in providing solutions to counter electronic fraud relating to an assortment of bank, card, internet and telephone channels. ValidSoft is the only security software company globally that has been granted three European Privacy Seals.
Earlier this month, ValidSoft announced that their Secure Mobile Architecture for Real-time Transactions (SMART™) was selected to be an integral element in the recently announced all-inclusive payment acceptance service solution to be provided by Spindle, Inc. (SPDL), a leading U.S.-provider of mobile payments solutions.
This week, ValidSoft announced that they achieved their main goal for their voice biometric technology of successfully being measured and compared with the world's leading commercial voice biometric providers and non-commercial voice biometrics research groups. ValidSoft clients are assured that they have access to a fully integrated, multi-layer, multi-factor authentication and transaction verification platform that can seamlessly incorporate world-leading voice biometric technology.
ValidSoft's solutions are utilized to verify the authenticity of both parties to a transaction (Mutual Authentication), the security of the relevant telecommunication channel used (Secure Communications), and the integrity of transactions itself (Transaction Verification) for the mass market, in a highly cost effective and secure manner while being very user-friendly.
Elephant Talk Communications Corp. (ETAK), closed Friday's trading session at $1.58, up 1.94%, on 101,160 volume with 279 trades. The average volume for the last 60 days is 224,691 and the stock's 52-week low/high is $0.77/$2.62.
Imaging Dynamics Co. Ltd. (IDL.TO)
We are highlighting Imaging Dynamics Co. Ltd. (IDL.TO), here at the QualityStocks Daily Newsletter.
Founded in 1995, Imaging Dynamics Co. Ltd. is an international leader in the high growth capital medical imaging equipment market. The Company engages in the field of digital radiography (DR) technology. Imaging Dynamics' shares trade on the Toronto Stock Exchange. The Company formerly went by the name Imaging Dynamics Corp. They changed their corporate name to Imaging Dynamics Co. Ltd. in October of 2001. The Company has their headquarters in Calgary, Alberta and has business offices in Hong Kong and Beijing, People's Republic of China (PRC).
A key part of the Imaging Dynamics' growing medical imaging product portfolio are the two platforms of digital radiography (DR) technology that enable the efficient capture of high resolution X-ray images with low dose to the patient. The Company's goal is to provide the highest image quality at an affordable system cost.
At present, the Company has more than 3,000 installations in 50 countries of their proprietary, award winning CCD-based X-Series direct capture technology. This technology replaces conventional film-based diagnostic imaging and provides a cost-effective solution for producing high quality diagnostic X-ray images.
Imaging Dynamics has received recognition by numerous industry organizations and research analysts throughout their history. This includes recognition from Frost & Sullivan and Deloitte Technology and PROFIT for their commitment to innovation, worldwide growth, as well as a customer focused value proposition.
In December 2012, Imaging Dynamics announced the appointment of new membership to the Company's Audit and Compensation Committees and the appointment of a new Corporate Secretary. Mr. Donald Brown will chair the Audit Committee with Mr. Earl Lande and Mr. Murray Wigmore as members. The Compensation Committee will be chaired by Mr. Earl Lande with Mr. Murray Wigmore and Mr. T.T. Lee as members. Mr. Jeffrey Graham was named as the Corporate Secretary of Imaging Dynamics.
In January, Imaging Dynamics announced the appointment of Ms. Anna Lentz, CGA, MBA, as Chief Financial Officer (CFO). Ms. Lentz has extensive experience in the financial management of private and public companies in the oil and gas, mining, engineering, and manufacturing sectors. She is currently the Principal of a privately owned financial consulting firm that provides the financial management and required controls for the success of their small to mid-sized clients.
Imaging Dynamics Co. Ltd. (IDL.TO), closed Friday's trading session at $0.015, up 50.00%, on 99,200 volume. The stock's 52-week low/high is $0.01/$0.03.
Canyon Gold Corp. (CGCC)
Today we are highlighting Canyon Gold Corp. (CGCC), here at the QualityStocks Daily Newsletter.
Trading on the OTC Bulletin Board, Canyon Gold Corp. is an Exploration Company. They plan to explore their claims for a large tonnage "Carlin" type of gold deposit. Canyon Gold plans to increase their claim holdings in the Long Canyon Trend - Spruce Ridge area (Carlin Gold Trend) through Spring/Summer 2013 by exercising an existing property lease option, subject to financing. Canyon Gold owns and or controls, through certain options, 310 mineral lease claims (6,613 acres) in the Spruce Ridge – Long Canyon Trend Area.
The Company's intention is to explore their claims for the same type of target, a large tonnage gold deposit akin to the West Pequop Mountains Long Canyon type of gold deposit. Canyon Gold will utilize comparable exploration techniques modified to fit the characteristics of the Spruce Hills property. Spruce Hills has fracturing and alteration similar to the West Pequop and Long Canyon gold deposits.
Last month, Canyon Gold announced their planned Phase Two Exploration as recommended by the Technical Report. The Company's Geologist, Mr. Alex Burton, following extensive on-site field inspection of Canyon Gold's mineral lease properties in Elko County, Nevada, completed all necessary field work for the completion and delivery to the Company of the 'Technical Report' on Canyon Gold's mineral lease claims.
The Report states in part, "The Canyon Gold Spruce Point claims have an equal chance as their neighbors to find gold mineralization in the hopes of proving up a mine. The initial examination studies showed similar conditions as at the Long Canyon deposit and that standard exploration techniques used for exploring for the Long Canyon type of Carlin trend ore body should work effectively on the Canyon Gold Corp. claims. The Canyon Gold property is well positioned geologically to explore for a western extension of the Long Canyon type of gold deposit."
Today, Canyon Gold announced that they engaged Omni Capital Corp., a Public Relations Group, to provide investor relations and shareholder communications services effective February 14, 2013. Omni Capital was awarded a services contract paying $10,000 per month for a one-year term. Omni Capital provides specialized consulting services to a select group of leading emerging and mid-capitalization companies.
Canyon Gold Corp. (CGCC), closed Friday's trading session at $0.46, even for the day, on 4,500 volume with 3 trades. The average volume for the last 60 days is 429 and the stock's 52-week low/high is $0.45/$0.75.
Mega Precious Metals, Inc. (MGP.V)
Stockhouse and Wall Street Reporter reported previously on Mega Precious Metals, Inc. (MGP.V), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Mega Precious Metals, Inc. is a mineral exploration company whose shares trade on the TSX Venture Exchange. The Company has a number of projects in Northwestern Ontario, Manitoba and Nunavut. Mega has a strong pipeline of mineralized targets for resource growth. Their main assets have numerous open pittable targets in addition to underground assets. Mega Precious Metals has their headquarters in Thunder Bay, Ontario.
Mega is targeting Production of greater than 200,000 ounces per year in both Red Lake and Monument Bay, Manitoba. The Red Lake Project consists of the North Madsen Properties, the Headway Property, and the Satterly Property. The Monument Bay Project, Mega Precious Metals', most advanced project, is located 570 km northeast of Winnipeg and 340 km east southeast of Thompson, Manitoba. The N.E. Manitoba property consists of 136 contiguous claims totaling more than 371km².
In November 2012, Mega Precious Metals announced that they made the final option payment to complete the acquisition of a 100 percent interest in the Headway property in Red Lake, Ontario. This consisted of the issue of 3,600,000 common shares to Kings Bay Gold Corp. and 400,000 common shares to Palomino Mining and Exploration Ltd. for the Headway Property. The 4,000,000 common shares issued by Mega are subject to a four-month hold period under Canadian securities laws, which expire on March 23, 2013.
The Headway property is situated along the Red Lake mine trend, and just South of Goldcorp's high grade Red Lake and Campbell mines located in Balmertown, Ontario. The property consists of six patented claims and one unpatented claim totaling approximately 320 acres. The Company believes that an opportunity exists on the Headway claims to encounter high-grade mineralization.
Last week, Mega Precious Metals announced that they started their 2013 exploration & drill program. They discovered high-grade concentrations of Tungsten at their high-grade multimillion-ounce gold deposit at the Monument Bay Gold Camp, in Manitoba. In mid-2012, the Company's geological team, in tandem with the University of Manitoba, determined that the gold mineralized zones have highly elevated concentrations of tungsten in the form of a mineral called Scheelite. Furthermore, Mega has begun an update of their National Instrument (NI) 43-101 Resource Estimate for the Twin Lakes Deposit and area within the Monument Bay Gold Camp.
Mega Precious Metals, Inc. (MGP.V), closed Friday's trading session at $0.23, down 6.12%, on 164,243 volume. The stock's 52-week low/high is $0.19/$0.74.
Buchans Minerals Corp. (BMC.V)
We are highlighting Buchans Minerals Corp. (BMC.V), here at the QualityStocks Daily Newsletter.
Buchans Minerals Corp. is a Resource Company that lists on the TSX Venture Exchange. The Company is focusing on developing their base metal properties and deposits in and around the famous Buchans mining camp in central Newfoundland. Currently, Buchans Minerals has two NI-43-101 compliant base metal deposits in and around Buchans, the Lundberg deposit located at the heart of the old Buchans mine and the Daniels Pond deposit located on the other side of the Red Indian Lake from Buchans. Buchans Minerals has their headquarters in Windsor, Nova Scotia.
The Company has three main assets that include their 100 percent owned base metal properties near Buchans in central Newfoundland (Joint Ventured to Minco plc.), their 100 percent owned manganese property located near Woodstock in New Brunswick (also Joint Ventured to Minco) and their 50 percent owned gold and copper Long Range Property in central Newfoundland.
On April 30, 2012, Buchans Minerals and Minco plc (AIM Market: MIO) announced an agreement granting Minco the right to earn a 51 percent interest in Buchans' base metal properties in central Newfoundland by spending $8 million to advance the Lundberg deposit to final feasibility over four years and further explore Buchans' extensive mineral properties in the region.
In January 2013, Buchans Minerals together with Minco announced remaining assays from their recently completed drilling program on the Lundberg and Engine House base metal deposits in Buchans, central Newfoundland. The three-month drilling program completed in October 2012; it consisted of 58 holes totaling 8,184 meters of drilling. Results for the final seven holes include additional favorable results confirming thick mineralization extending to depth within the resource's northwestern area. The results also confirm that the resource extends further east than previously interpreted.
Results from the northwest area include multiple thick intercepts that further confirm the resource in this key area. Results include 43 meters averaging 2.37 percent combined base metals consisting of 0.15 percent copper, 0.69 percent lead, and 1.52 percent zinc in hole 3477. Highlights from the east margin of the Lundberg zone include an intercept of 37.7 meters averaging 1.01 percent combined base metals consisting of 0.23 percent copper, 0.15 percent lead and 0.63 percent zinc beneath 11.3 meters of overburden in hole 3482.
A second hole drilled in this area, 3483, also intersected mineralization immediately below overburden coring 16.55 meters averaging 1.79 percent combined base metals comprised of 0.26 percent copper, 0.42 percent lead and 1.11 percent zinc. Results from these two holes suggest the zone remains open beyond the eastern limits of the previous resource estimate.
Yesterday, Buchans Minerals and Minco announced initial drilling results for the Woodstock manganese project in New Brunswick. The first hole of the current program, PL-11, underwent drilling at the northwest end of a line of previously drilled holes and completes a central section across the deposit. The new hole, PL-13-011, has returned assays averaging 11.25 percent Manganese over 113.85 meters core length (95 m approximate true width).
Buchans Minerals Corp. (BMC.V), closed Friday's trading session at $0.045, up 12.50%, on 80,000 volume. The stock's 52-week low/high is $0.03/$0.11.
International Stem Cell Corp. (ISCO)
The QualityStocks Daily Newsletter would like to spotlight International Stem Cell Corp. (ISCO). Today, International Stem Cell Corp. closed trading at $0.345, up 7.48%, on 293,262 volume with 79 trades. The stock’s average daily volume over the past 60 days is 219,681, and its 52-week low/high is $0.161/$0.65.
International Stem Cell Corp. announced some key amendments to the 2004 license agreements (previously amended in 2005) with Advanced Cell Technology today that cover a vast patent and application framework for certain essential tissue technologies. The amendments effectively extend ISCO's parthenogenesis IP portfolio, opening up a whole range of therapeutic and business opportunities, as well as making partnerships with big pharma practical. ISCO now has an exclusive world-wide license to ACT's patents and applications covering the uses of parthenogenetically derived stem cells in generating human tissue.
International Stem Cell Corp. (ISCO) specializes in the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. The company was first to perfect the natural phenomenon of parthenogenesis, which utilizes unfertilized human eggs to create hpSCs. These stem cells, created in a particular form called HLA homozygous, can be immune-matched to millions of people regardless of sex or racial background, with minimal expectation of immune rejection after transplantation.
hpSCs are as pluripotent as embryonic stem cells (ESCs) and have significant therapeutic potential but their creation does not involve the destruction of a viable human embryo – thus sidestepping the controversy and ethical dilemmas associated with the use of human embryonic stem cells. Different from induced pluripotent stem cells (iPSs), hpSCs do not involve manipulation of gene expression back to a less differentiated stage – a practice that may become a safety or regulatory obstacle in clinical applications.
A relatively small number of hpSC lines can offer the potential of producing the first true stem cell bank, UniStemCell, which ISCO intends to create as a means of serving populations across the globe. The company's scientists are currently focused on using hpSC to treat severe diseases of the eye, nervous system, and liver, for which cell therapy has been clinically proven but is limited due to the unavailability of safe human cells.
In addition to its therapeutic focus, ISCO also provides two revenue streams. Firstly through its subsidiary Lifeline Cell Technology, specialized cells and growth media for biological research around the world, and secondly its subsidiary Lifeline Skin Care, the company manufactures and sells anti-aging skincare products utilizing an extract from the hpSC and by leveraging the latest discoveries in the fields of stem cell biology, nanotechnology, and skin cream formulation technology. Disclaimer
International Stem Cell Corp. Company Blog
International Stem Cell Corp. News:
International Stem Cell Corporation Strengthens Intellectual Property Portfolio
International Stem Cell Corporation Demonstrates Positive Animal Efficacy Results in Metabolic Liver Disease Program
International Stem Cell Corporation Announces Positive Results From In Vivo Animal Study of Parkinson's Disease
Advaxis, Inc. (ADXS)
The QualityStocks Daily Newsletter would like to spotlight Advaxis, Inc. (ADXS). Today, Advaxis, Inc. closed trading at $0.112, up 40.00%, on 7,327,152 volume with 417 trades. The stock’s average daily volume over the past 60 days is 4,528,718, and its 52-week low/high is $0.0275/$0.155.
Advaxis, Inc. (ADXS) is a clinical-stage biotechnology company developing the next-generation of immunotherapies for cancer and infectious diseases. The company’s immunotherapies are based on a novel platform technology that uses live, bio-engineered bacteria to secrete an antigen/adjuvant fusion protein that redirects the powerful immune response all human beings have to fight off cancer and disease.
The company has more than fifteen distinct constructs in various stages of development, all of which are involved in strategic collaborations with recognized centers of excellence such as the National Cancer Institute, Cancer Research – UK, the Wistar Institute, the University of Pennsylvania, the University of British Columbia, the Karolinska Institutet, and others.
Advaxis’ lead construct, ADXS-HPV, is currently in Phase 2 clinical development for recurrent/refractory and advanced cervical cancer, CIN 2/3, and HPV caused head and neck cancers. This important construct was recognized as the Best Therapeutic Vaccine (approved or in development) at the 5th Annual Vaccine Industry Excellence (ViE) Awards by the vaccine industry and the journal Expert Reviews of Vaccines.
The estimated global market for immunotherapies is projected to exceed $37.2B by 2012, with cancer vaccines forecast to grow into an $8B market. Protected by 77 issued and pending patents, Advaxis is extremely well positioned to capitalize on the burgeoning opportunities in the healthcare sector as it advances the development of next-generation treatments for today’s most challenging diseases. Disclaimer
Advaxis, Inc. Company Blog
Advaxis, Inc. News:
Chairman and CEO of Advaxis Featured in Exclusive SmallCapVoice Interview
Advaxis to Present at the 15th Annual BIO CEO & Investor Conference
Advaxis to Present at the 6th Annual OneMedForum
Rafarma Pharmaceuticals, Inc. (RAFA)
The QualityStocks Daily Newsletter would like to spotlight Rafarma Pharmaceuticals, Inc. (RAFA). Today, Rafarma Pharmaceuticals, Inc. closed trading at $0.80, up 33.33%, on 3,740 volume. The stock’s 52-week low/high is $0.65/$0.80.
Rafarma Pharmaceuticals, Inc. (RAFA) is a multiproduct pharmaceutical company specializing in the production of generic antibiotics and specialty pharmaceuticals, including its own proprietary products approved by the ministry of health. Rafarma stands as one of the most ambitious projects in recent medical history, having constructed the most technologically advanced pharmaceutical plant in Russia.
Based in Terbuny, Lipetsk region, Russia, Rafarma possesses a unique niche in the burgeoning pharmaceutical market and is poised to become a major player in the international drug industry. The company was established under the auspices of the Foundation to Support Health Care and has been approved by the Ministry of Health.
Rafarma recently received the general license for pharmaceutical products and began manufacturing three new products: Sodium Para-Aminosalicilate, Ibuprofen, and Betagistin. Receiving the general license was one of the final steps the company needed to open its new plant in Terbuniv, and Rafarma has been named one of only four national strategic pharmaceutical suppliers to the Russian Federation.
Advances in health care science, medicine, and technology have increased the general life expectancy of Eastern European citizens steadily over the past decade. Elderly citizens, which comprise the largest portion of the pharmaceuticals market, have bolstered demand for pharmaceuticals nationwide. Rafarma is well positioned to capitalize on the expanding industry with its strong relationships and state-of-the-art production facility. Disclaimer
Rafarma Pharmaceuticals, Inc. Company Blog
Rafarma Pharmaceuticals, Inc. News:
Rafarma Pharmaceuticals, Inc. Receives General License for Pharmaceutical Products and has Started to Manufacture 3 New Products
Rafarma Pharmaceuticals, Inc. Named 1 Of 4 National Strategic Pharmaceutical Suppliers To The Russian Federation
Rafarma Pharmaceuticals, Inc. Achieves Full Certification
TNI BioTech, Inc. (TNIB)
The QualityStocks Daily Newsletter would like to spotlight TNI BioTech, Inc. (TNIB). Today, TNI BioTech, Inc. closed trading at $5.90, up 5.36%, on 30,696 volume with 76 trades. The stock’s average daily volume over the past 60 days is 22,009, and its 52-week low/high is $0.72/$15.80.
TNI BioTech, Inc. (TNIB) is focused on utilizing patented immunotherapy to activate and mobilize the body's immune system to combat fatal diseases. The company's products and technologies improve the treatment and diagnosis of cancer, infections such as HIV/AIDS, and autoimmune diseases. Future initiatives include treatment for multiple sclerosis, herpes viral infections, and other conditions that result in altered-immune response.
The company's product portfolio currently includes IRT-101, an active immunotherapy that works by activating a patient's immune system against infectious diseases and tumor cells; IRT-102, an adaptive immunotherapy that works by isolating and enriching a patient's own immune cells; and IRT-103, an active immunotherapy that works by activating a patient's immune system against HIV/AIDS and tumor cells.
Leveraging the advantages of today's cutting-edge treatment options, the company aims to meet the growing demand for quality healthcare with safer, more effective radiation therapy; new-targeted drug therapies; and minimally invasive surgical alternatives around the world. TNI BioTech most recently signed a letter of intent to open clinics in Africa that will provide advanced treatment for cancer, HIV/AIDS, and autoimmune diseases.
The company plans to continue clinical trials in China during 2012 and 2013, and anticipates starting trials in the United States by early 2013.The company is also in negotiations to acquire a number of other immunotherapy products, patents, and therapies. Led by a management team with decades of experience and solid business plan, TNI BioTech is poised to improve healthcare with active and adaptive forms of improved immunotherapies. Disclaimer
TNI BioTech, Inc. Company Blog
TNI BioTech, Inc. News:
TNI BioTech Secures Exclusive License to Portfolio of Cancer Treatment and Prevention-Related IP
TNI BioTech, Inc. Announces Appointment of New CFO
TNI BioTech, Inc. Acquires the Exclusive Rights to Low Dose Naltrexone and Other Antagonists for Treatment of Bowel Diseases
International Stem Cell Corp., a California-based biotechnology company specializing in the therapeutic applications of human parthenogenetic stem cells (hpSCs), just announced that amendments have been made to its license agreements with Advanced Cell Technology, Inc.
First entered into in 2004, the license agreements provide access to an array of patents and patent applications for the use of various technologies in certain human tissues.
Through these amendments, ISCO has extended its existing rights in the area of parthenogenesis, as well as the therapeutic use of parthenogenetically derived stem cells for treating any human diseases. ISCO now has an exclusive worldwide license to ACT’s patents and applications covering the uses of parthenogenetically derived stem cells in generating human tissue.
“We’re excited to have extended our portfolio of intellectual property which not only allows us to develop new therapeutic and business opportunities, but also makes the possibility of partnering with big pharma practical,” commented Dr. Andrey Semechkin, CEO and Co-Chairman of ISCO.
For more information, visit www.internationalstemcell.com
Cloud technology, in its many and varied manifestations, is becoming as big a revolution for the Internet as the Internet itself has been for business and personal communication. Computers by themselves allow us to store and process tremendous amounts of information on a local basis. The Internet has allowed us to link the world’s computers, effectively replacing the information on our local computer with virtually unlimited information through the global computer network.
Today, cloud technology is pursuing the next logical step, allowing us to capture and utilize not just information but processing functionality from all over the world. In effect, we are taking the critical first steps toward creating a truly world computer, unbounded by geographical location or local resources, where even the smallest organizations have access to big data and big processing. These initial steps are already providing cost savings and capabilities that are driving a growing demand for cloud technology, an industry that is now expected to approach $50 billion within the next several years.
GlobalWise Investments, through its Intellinetics subsidiary, offers a good example of the power of the cloud to make life easier and more productive for commercial and government entities. Intellinetics Intellivue Document Management Platform is an intelligent ECM (Enterprise Content Management) technology platform that easily integrates into a company’s current host business application.
GlobalWise Investments provides clients with a simple and standardized way to quickly organize large volumes of current paper or unstructured electronic files into process-ready information. Using the latest cloud advances, the company’s platform technology lets authorized users access and process all forms of collected information on a 24/7 basis, from anywhere on the planet. In effect, the client user can take the company with them wherever they go, representing a major potential leap in communication and productivity at a fraction of the cost required in the pre-cloud world.
For additional information, visit www.GlobalWiseInvestments.com
Intravascular robotics leader Hansen Medical announced that Will Sutton has been appointed to the newly created position of Chief Operating Officer. Reporting directly to President and CEO Bruce Barclay, Mr. Sutton will manage and oversee the company’s engineering and manufacturing functions. Hansen Medical created this position to enhance collaboration on product development and manufacturing, which is consistent with its commitment to bringing innovative products and capabilities to the market with improved product margins.
“I am excited to join the Hansen Medical team at such an important inflection point in the Company’s history,” said Mr. Sutton. “I look forward to utilizing my experience in operations management, research, product development, and manufacturing to help Hansen Medical achieve operational and commercial excellence.”
Prior to joining Hansen, Mr. Sutton has spent the past 10 years at St. Jude Medical in increasingly senior positions. As Vice President of Research and Development of the Atrial Fibrillation (AF) Division, Mr. Sutton directed strategic R&D activities for global interventional electrophysiology products. He also managed a 270-person department and a portfolio of over 30 annual projects. During his six years in this role, revenue in the St. Jude’s AF Division grew from $145 million to over $880 million. Mr. Sutton also served as the Director of R&D for the St. Jude’s Cardiac Surgery Division and Vice President of Program Management for the AF Division. In this role, he oversaw day-to-day strategic R&D activities and ensured project performance to timeline, budget, features, and success metrics.
Mr. Sutton began his career as a development engineer in the Diagnostics Division of Abbott Labs, and holds a B.S. and M.S. in mechanical engineering from Stanford University.
“Will has extensive operations, research, product development, and manufacturing experience in the medical technology space, both in capital equipment and disposables, and within both the EP and vascular markets,” said Mr. Barclay. “His background is ideal for the newly created COO position. As Hansen Medical sharpens its operational and commercial focus, it is imperative that we have the organizational structure, and experienced leadership to maximize profitability and ensure long-term commercial success.”
He continued, “Will’s appointment, as well as the recently announced appointment of Bob Cathcart to the position of Senior Vice President of Global Sales, provides Hansen Medical with two additional, highly experienced senior executives with proven commercial success in support of this objective. I am confident that Will’s expertise will be invaluable to our Company as we expand the launch of our Magellan™ Robotic System, and continue to advance our product pipeline.”
For more information on Hansen Medical, visit www.hansenmedical.com
TechPrecision, a global manufacturer of large-scale, metal fabricated, and machined precision components, today said its subsidiary, Ranor, has shipped the first AOS-100A Isotope Transport Cask to a commercial customer of Alpha-Omega Services Inc., reflecting a long-standing collaboration.
The units were approved by the Nuclear Regulatory Commission (NRC), as Ranor has passed the NRC manufacturing process and quality audit for the cask production in March of 2012.
“This shipment marks a milestone for TechPrecision’s Ranor subsidiary, for Alpha-Omega Services, and for the nuclear industry,” James Molinaro, CEO of TechPrecision stated in the press release. “This isotope transport cask enables safe transport of isotopes, and represents the first new cask to be approved by the NRC in decades. Today, thousands of hospitals use isotopes for radiotherapy, and will need these types of casks to transport the isotopes in accordance with the current NRC requirements. This represents a significant growth opportunity both for our partner, Alpha-Omega Services, and for Ranor.”
TechPrecision, Ranor and Alpha-Omega have devoted considerable time and costs to complete the first cask, which paves the way for additional casks to be delivered in upcoming months.
“After seven years and $8 million, this is a monumental day for all of my employees and our current and future customers,” Troy Hedger, president, Alpha-Omega stated. “My sincere ‘thank you’ goes out to each one for their patience and continued belief in this product. AOS, TechPrecision and Ranor, over the past 13 months, have worked aggressively to complete the manufacturing of this first cask and in the process have uncovered ways to shorten the time from order to completion. When fully implemented this will be beneficial for the next five casks which are to be delivered over the next few months and is an important factor for those commercial U.S.-based orders we anticipate to be placed now that the cask is a real choice for those who will be required to replace their cask fleets.”
For more information, visit www.techprecision.com
Today's Top 3
Investor News Source
The QualityStocks Public Company Sponsor News
- Get profiles for new featured companies at clients.qualitystocks.net
- Advaxis, Inc. (ADXS) Chairman and CEO Featured in Exclusive SmallCapVoice Interview
- Bergamo Acquisition Corp. (BGMO) Provides Authenticated Documentation to Confirm Bank Deposits
- Consorteum Holdings, Inc. (CSRH) Reaches Funding Agreement With Private Equity Group
- Cardium Therapeutics, Inc. (CXM) Announces Presentation at The 2013 Cell & Gene Therapy Forum
- GlobalWise Investments, Inc. (GWIV) CEO to Speak at Technology United Executive Conference
- International Stem Cell Corp. (ISCO) Strengthens Intellectual Property Portfolio
- Loans4Less.com, Inc. (LFLS) Engages CPA Firm to Audit Financials
- Rafarma Pharmaceuticals, Inc. (RAFA) Receives General License for Pharmaceutical Products Starts Mfg. 3 New Products
- Rainbow Coral Corp. (RBCC) Retains New IR Group to Optimize Investor Outreach, Relay Key Growth Plans
- TNI BioTech Inc. (TNIB) Secures Exclusive License to Portfolio of Cancer Treatment and Prevention-Related IP
- Viaspace, Inc. (VSPC) 25 Acres of Giant King Grass Shipped and Growing in St. Croix
- Viscount Systems, Inc. (VSYS) Awarded Contract to Secure Additional U.S. Government Facilities
- VistaGen Therapeutics, Inc. (VSTA) Becomes Member of Centre for Commercialization of Regenerative Medicine Consortium